monomorphic epitheliotropic intestinal T-cell lymphoma | Clinical Trials Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

66,256 results for “monomorphic epitheliotropic intestinal T-cell lymphoma”

Need more precision?

Filter by phase, recruitment status, country, sponsor, age, and study type.

Refine trial search

Tazemetostat Plus CHOP in 1L T-cell Lymphoma

24 participants · First posted Nov 18, 2024

Dose-Escalation and Dose-Expansion Study to Evaluate the Safety and Tolerability of Anti-CD7 Allogeneic CAR T-Cells (WU-CART-007) in Patients With CD7+ Hematologic Malignancies

6 participants · First posted May 17, 2022

Not yet recruiting

Go-CHOP in de Novo Intestinal T-cell Lymphoma Patients

7 participants · First posted Nov 22, 2024

Not yet recruiting

Belinostat in Combination With Azacitidine or Pralatrexate for the Treatment of Relapse or Refractory T-cell Lymphoma

40 participants · First posted Jul 9, 2026

A Registry for People With T-cell Lymphoma

1,000 participants · First posted Aug 7, 2023

Doxorubicin, CC-(486) (5-azacitidine), Romidepsin, and Duvelisib (hARD) for T-cell Lymphoma

First posted Nov 23, 2020

Depsipeptide to Treat Patients With Cutaneous T-Cell Lymphoma and Peripheral T-Cell Lymphoma

131 participants · First posted Dec 18, 2000

Active, not recruiting

Pembrolizumab and Pralatrexate in Treating Patients With Relapsed or Refractory Peripheral T-Cell Lymphomas

13 participants · First posted Jul 26, 2018

CD7 CAR-T Cells in T-cell Lymphoma/Leukemia

20 participants · First posted Nov 17, 2022

High-Dose Chemotherapy Given Together With Peripheral Blood Stem Cell Transplant in Treating Patients With Intestinal T-Cell Lymphoma

60 participants · First posted May 1, 2008

Page 1 of 4690